Jump to navigation

  • Contact us
  • Data catalog (GHDx)
  • Research library
Home
Main menu
  • Home
  • Research and analysis
    • Global Burden of Disease (GBD)
    • Health policy and planning
    • Health by location
      • Country profiles
      • US health
      • Disease burden in India
    • Health risks and issues
    • Diseases and injuries
    • Training on our research
    • Research and news library
  • Data tools and practices
    • Interactive data visuals
    • Data sources
    • How we collect data
    • Data practices
    • Verbal autopsy tool
    • Training on tools
    • Data for the private sector
  • News and events
    • News media
    • Blogs
    • Events
    • Media contacts
  • About us
    • Vision and mission
    • Diversity, Equity, and Inclusion
    • Our people
    • Awards
    • Careers
    • History
    • Governance
    • Contact us

Explore section

Research & Analysis

  • Global Burden of Disease (GBD)
  • Health policy and planning
  • Health by location
    • Country profiles
    • US health
    • Disease burden in India
  • Health risks and issues
  • Diseases and injuries
  • Training on our research
  • Research and news library

Country profiles


12345678910
1=not very likely; 10=extremely likely: *

The Country Profiles provide an overview of findings from the Global Burden of Disease (GBD). They are based on over 80,000 different data sources used by researchers to produce the most scientifically rigorous estimates possible. Estimates from the GBD study may differ from national statistics due to differences in data sources and methodology. These profiles are meant to be freely downloaded and distributed. Please send feedback and questions to [email protected].

SUGGESTED CITATION

Institute for Health Metrics and Evaluation (IHME). [INSERT LOCATION NAME] profile. Seattle, WA: IHME, University of Washington, 2021. Available from http://www.healthdata.org/[INSERT LOCATION NAME]. (Accessed [INSERT DATE])

TERMS DEFINED

Expected value

The expected value is the predicted indicator value based on the country's per capita income, educational attainment, and total fertility rate.

Observed value

The observed value is the actual indicator value for the country.

Life expectancy

Life expectancy is the number of years that the average member of a group can expect to live. Many things can affect a group’s life expectancy, including things like death rates in children, income, access to health care, diet, and environment. Life expectancy in a group even changes over time as new life-saving technologies emerge, a civil war occurs, or other things happen. Since 1990 life expectancy at birth has increased in most places around the world.

Under-5 mortality

Under-5 mortality is the chance that a child will die before his or her fifth birthday. Health policymakers worldwide have used under-5 mortality as a key indicator of progress in global health and have made the reduction of under-5 mortality a primary goal.

Cause of death

Cause of death estimates show the root causes of deaths within a group, usually expressed as a rate (e.g., deaths per 100,000 population). These are the underlying causes of death, so, for example, if a person dies in a car accident, we attribute their death to the car accident itself and not a particular injury caused by the accident. 

YLLs

YLLs stands for years of life lost. It is a measure of premature death within a group of people. YLLs are calculated by starting with the highest achievable life expectancy in a given year for a given age group, then subtracting the age at which a person in that age group dies. For example, if achievable life expectancy in a given year for men is 81 years, a man who dies of lung cancer at age 65 will have 16 years of life lost. 

YLDs

YLDs stands for years lived with disability. It measures the amount of time people lose to diseases and injuries that degrade health but do not cause death. It is calculated by multiplying a disability’s severity by the time it lasts. This means that a short-term, severe health problem and a long-term, relatively mild health problem could both result in the same number of YLDs. For example, someone who needs two months to recover from a car accident but then regains their full health and someone who experiences relatively mild but lifelong back pain could end up losing the same number of years of their lives to disability. YLDs take into account all disabilities, including lower-visibility ones that result in daily pain, lost work time, or an inability for someone to thrive as they otherwise might.

DALYs

DALY stands for disability-adjusted life years. It is the sum of YLLs and YLDs, so DALYs take into account both premature death and health-related suffering to portray the total years of healthy life lost from all causes. Ranking the causes of DALYs in a population shows the health problems that cause the most suffering in a society, whether it is by killing people when they are very young, by shortening by a few years the lives of many people, or by causing daily, long-term suffering for many people.

Risk factor

A risk factor is any modifiable behavior or condition that increases the likelihood that a person will experience a negative health event. That event could be getting an illness, having an accident that causes injury or death, or dying prematurely for any reason. If, over time, people engage in less risky behavior, or if fewer people live in risky conditions, then the incidence of health problems associated with that risk factor should go down.

Related Content

Related Content

More Data - GHDx

Data Visualizations

GBD Compare

Analyze updated data about the world’s health levels and trends from 1990 to 2019 in this interactive tool using estimates from the Global Burden of Disease (GBD) study. Compare causes,...

Publications

Read the research on cancer in North Africa and the Middle East.
Burden of tracheal, bronchus, and lung cancer in North Africa and Middle East countries, 1990 to 2019: Results from the GBD study 2019

Researchers found that tobacco use is still a leading cause of tracheal, bronchus, and lung cancer in the region.

Read the research on maternal deaths in Iran.
Levels and trends of maternal mortality and morbidity by cause in North Africa and Middle East, 1990 to 2019: An analysis for the Global Burden of Disease study 2019

Maternal mortality has significantly declined in the region since 1990 and only five countries (Afghanistan, Sudan, Yemen, Morocco, and Algeria) out of 21 nations didn’t achieve the...

Read the research on infant and child death in Iran.
Neonate, infant, and child mortality by cause in provinces of Iran: An analysis for the Global Burden of Disease study 2019

All provinces achieved the Sustainable Development Goal 3.2 of neonatal mortality less than 12 and child mortality less than 25 per 1000 live births. However, disparities still exist across...

Read the research on substance use in South America.
Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019

This study investigated the burden of disease attributable to amphetamine use disorder, cannabis use disorder (CAD), cocaine use disorder, and opioid use disorder (OUD) in South America from...

Read the research on disease burden in Pakistan.
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Comparison of health indicators since 1990 provides valuable insights about Pakistan's ability to strengthen its health-care system, reduce inequalities, improve female and child health...

Read the research on tuberculosis in Cambodia.
Progress towards the 2020 milestones of the end TB strategy in Cambodia: estimates of age and sex specific TB incidence and mortality from the Global Burden of Disease Study 2019

We aimed to examine the levels and trends in the fatal and non-fatal TB burden in Cambodia from 1990 to 2019, assessing progress towards the WHO End TB interim milestones, which aim to reduce...

Read the research on mortality associated with bacterial pathogens.
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019

We estimated deaths associated with 33 bacterial genera or species across 11 infectious syndromes in 2019 using methods from the Global Burden of Diseases, Injuries, and Risk Factors Study (...

Read the research on benign prostatic hyperplasia.
The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019

As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we estimated global trends in, and prevalence of, benign prostatic hyperplasia and disability-adjusted...

Read the research on GBD results for Indonesia's provinces.
The state of health in Indonesia’s provinces, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Long-term analyses of disease burden provide insights on Indonesia’s advance to universal health coverage and its ability to meet the United Nations Sustainable Development Goals by 2030.

Read the research on health care access and quality.
Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

Drawing from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019), we measured the Healthcare Access and Quality (HAQ) Index overall and for select age groups in...

Related Content

Data visualizations

GBD Compare
Analyze updated data about the world’s health levels and trends from 1990 to 2019 in this interactive tool using estimates from the Global Burden of Disease (GBD) study. Compare causes, injuries,...

Publications

Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
The UN’s Sustainable Development Goals (SDGs) are grounded in the global ambition of “leaving no one behind.” Understanding today’s gains and gaps for the health-related SDGs is essential f...
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
Detailed assessments of mortality patterns, particularly age-specific mortality, represent a crucial input that enables health systems to target interventions to specific populations. Understanding...
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
Monitoring levels and trends in premature mortality is crucial to understanding how societies can address prominent sources of early death. The Global Burden of Disease 2016 Study (GBD 2016) provid...
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global B...
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Measurement of changes in health across locations is useful to compare and contrast changing epidemiological patterns against health system performance and identify specific needs for resource allo...
Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of risk factor exposure and attributable burden of disease. By providing estimate...

Projects

Global Burden of Disease (GBD)
GBD is the most comprehensive effort to date to measure epidemiological levels and trends worldwide. It is the product of a global research collaborative and qua...

Datasets

Countries

Research & Analysis

  • Global Burden of Disease (GBD)
  • Health policy and planning
  • Health by location
    • Country profiles
    • US health
    • Disease burden in India
  • Health risks and issues
  • Diseases and injuries
  • Training on our research
  • Research and news library

Sign up for IHME News

Stay connected

    

Sign up for our newsletter

  • Contact us
  • Donate
  • Privacy policy

© 2023

         Home to Highly Cited Researchers 2022, Clarivate

  • Home
  • Research and analysis
    • Global Burden of Disease (GBD)
    • Health policy and planning
    • Health by location
    • Health risks and issues
    • Diseases and injuries
    • Training on our research
    • Research and news library
  • Data tools and practices
    • Interactive data visuals
    • Data sources
    • How we collect data
    • Data practices
    • Verbal autopsy tool
    • Training on tools
    • Data for the private sector
  • News and events
    • News media
    • Blogs
    • Events
    • Media contacts
  • About us
    • Vision and mission
    • Diversity, Equity, and Inclusion
    • Our people
    • Awards
    • Careers
    • History
    • Governance
    • Contact us